Shamrock Industrial Company Ltd.

9.55 -0.45 ▼-4.5%

28 March 2024, 04:01:00 PM
Volume: 2,642

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.shamrockindustrial.wordpress.com
Market Cap 5.21 Cr.
Enterprise Value(EV) 5.21 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.08 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 3.22 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.98 Calculated using Price: 9.60
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.54 Cr. 5,428,414 Shares
FaceValue 10
About Shamrock Industrial Company Ltd.
Shamrock Industrial Company (SICL) is the manufacturing division of Shamrock Group of Companies, who have been primarily involved in the field of Pharmaceutical Raw Materials, Intermediates and Fine Chemicals since the past 23 years.

Shamrock Industrial Company Ltd. Delivery

Delivered Qty
Traded Qty

Shamrock Industrial Company Ltd. Performance

1 Day
-4.50%
1 Week
-3.44%
1 Month
-12.86%
3 Month
+11.70%
6 Month
+111.75%
1 Year
+146.77%
2 Year
+45.58%
5 Year
10 Year

Shamrock Industrial Company Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -4.31 -105.51 -1.85 -2.17 -10.35 -8.68 -13.86 -10.35 -7
Return on Capital Employed (%) -0.41 -21.87 -0.74 -0.85 -5.66 -8.68 -13.86 -10.35 -6.96
Return on Assets (%) -0.35 -21.57 -0.73 -0.84 -5.41 -8.01 -13.58 -10.12 -6.87

Shamrock Industrial Company Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 3 3 3 3 2 2 2 2 2
Non Curr. Liab. 9 0 0
Curr. Liab. 2 5 5 5 0 0 0 0 0 0
Minority Int.
Equity & Liab. 11 8 8 8 3 2 2 2 2 2
Non Curr. Assets 10 8 8 8 0 0 0 0 0 0
Curr. Assets 2 0 0 0 3 2 2 2 2 2
Misc. Exp. not W/O
Total Assets 11 8 8 8 3 2 2 2 2 2

Shamrock Industrial Company Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0
Other Income 2 0 0 0
Total Income 2 0 0 0 0
Total Expenditure 0 -3 0 0 -4 0 0 0 0 0
PBIDT 0 -2 0 0 -4 0 0 0 0 0
Interest 0
Depreciation
Taxation
Exceptional Items 3
PAT 0 -2 0 0 0 0 0 0 0 0
Adjusted EPS 0 -4 0 0 -1 0 -1 0 0 0

Shamrock Industrial Company Ltd. Cash Flow

Particulars 10 years 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -2 -9 -1 0 0 0
Cash Fr. Inv. 2 11
Cash Fr. Finan.
Net Change 0 0 2 -1 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 2 2 1 1 1

Shamrock Industrial Company Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 42.98 42.98 42.98 42.98 42.98 42.98 42.98 42.98 42.98
Public 57.02 57.02 57.02 57.02 57.02 57.02 57.02 57.02 57.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Shamrock Industrial Company Ltd. Announcements

Thu, 28 Mar 2024
Closure of Trading Window
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Shamrock Industrial Co. Ltd.s code of conduct for insiders" the Trading Window for dealing in securities of the company shall remain close for the Designated person (as defined in the Code) from close of Business hours of 31st March 2024 till 48 hours after the announcement of the Audited Financial Result of the company for the quarter and the year ended 31st march 2024.
Thu, 07 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation Regarding Loss of Share Certificate under Regulation 39(3) of SEBI (LODR) 2015
Mon, 12 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR) Regulation 2015 please fInd enclosed copy of Newspaper cutting in connection with publication made by the company for its Financial results for the quarter and nine months ended 31.12.2023 published in the newspaper dated 11.02.2024

Shamrock Industrial Company Ltd. Technical Scans

Thu, 28 Mar 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low

Shamrock Industrial Company Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Shamrock Industrial Company Ltd. FAQ's

What is Shamrock Indl. Co share price?

Can I buy Shamrock Indl. Co shares now?

What is the Market Cap of Shamrock Indl. Co?

What are the key metrics to analyse Shamrock Indl. Co?

What is the 52 Week High and Low of Shamrock Indl. Co?

What is the trend of Shamrock Indl. Co share price?